During the past decade, Providence Cancer Center at Providence Portland Medical Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 57 clinical trials were completed, i.e. on average, 228% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 8 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Cancer Center at Providence Portland Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 44 trials, followed by "Alliance for Clinical Trials in Oncology" with 30 trials sponsored, "Radiation Therapy Oncology Group" with 13 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored and "Pfizer" with 6 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Cancer Center at Providence Portland Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 103 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Providence Cancer Center at Providence Portland Medical Center" are "Breast Cancer" (25 trials), "Lymphoma" (16 trials), "Lung Cancer" (14 trials), "Colorectal Cancer" (7 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (7 trials). Many other conditions were trialed in "Providence Cancer Center at Providence Portland Medical Center" in a lesser frequency.

Most popular intervention types in "Providence Cancer Center at Providence Portland Medical Center" are "Drug" (95 trials), "Biological" (39 trials), "Other" (28 trials), "Radiation" (26 trials) and "Procedure" (24 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (12 trials), "cyclophosphamide" (11 trials), "placebo" (11 trials), "cisplatin" (10 trials) and "cetuximab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Providence Cancer Center at Providence Portland Medical Center" are 106 trials for "All" genders, 23 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Cancer Center at Providence Portland Medical Center". undefined are not yet recruiting, 9 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 92 completed trials in Providence Cancer Center at Providence Portland Medical Center, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Cancer Center at Providence Portland Medical Center, 17 "Phase 1" clinical trials were conducted, 61 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".